{"id":1233560,"recorded_at":"2026-10-30T08:04:14.237025Z","observed_at":"2026-10-30T08:04:14.236963Z","subject_kind":"endpoint","subject":"734d5005-079d-4dac-8f85-a79df1a9161d","kind":"mcp.tools","method":"probe.mcp/1","body":{"count":4,"tools":[{"description":"PRO. Trial counts per year and most common co-listed conditions for a keyword — competitive landscape.","inputSchema":{"properties":{"access_token":{"description":"Subscriber token from /success (or Authorization: Bearer)","type":"string"},"keyword":{"type":"string"}},"required":["keyword"],"type":"object"},"name":"condition_landscape"},{"description":"PRO. Live detail for a protocol id: sponsor/manufacturer, drug products and study population.","inputSchema":{"properties":{"access_token":{"description":"Subscriber token from /success (or Authorization: Bearer)","type":"string"},"protocol_id":{"type":"number"}},"required":["protocol_id"],"type":"object"},"name":"trial_detail"},{"description":"FREE. Health Canada-authorised clinical trials for a condition or drug keyword — newest 5.","inputSchema":{"properties":{"keyword":{"type":"string"}},"required":["keyword"],"type":"object"},"name":"trial_search"},{"description":"PRO. Up to 200 trials for a keyword, optionally started since a date.","inputSchema":{"properties":{"access_token":{"description":"Subscriber token from /success (or Authorization: Bearer)","type":"string"},"keyword":{"type":"string"},"since":{"type":"string"}},"type":"object"},"name":"trial_search_full"}]},"body_sha256":"9b588d243f20aa4ebc90e1f1b9c9bd9b430183dc8db9adbe1b9eab685bae5495","prev_id":null,"leaf":"0xb62575fcb6893d9e799f21a26b1c502121ff374748bb7d7d8d07ff42eb890edb","leaf_text":"{\"body\":\"9b588d243f20aa4ebc90e1f1b9c9bd9b430183dc8db9adbe1b9eab685bae5495\",\"id\":1233560,\"kind\":\"mcp.tools\",\"method\":\"probe.mcp/1\",\"observed_us\":1793347454236963,\"prev\":null,\"subject\":\"734d5005-079d-4dac-8f85-a79df1a9161d\",\"subject_kind\":\"endpoint\"}","day":{"day":"2026-10-30","leaves":243099,"root":"0x0826c7ad6039e06a2360ca0a4a3a4fe7f2626c6dc19f71a37599386f78b39875","chained":"0x36b4c8a1063758f0b8765fa1bdf75fa92fb543cc183add3e261880ee2bd1f822","anchor_chain":"eip155:5042002","anchor_tx":"0x8704744146c6967c8abc9e9a99de4db7283b29e840922ea83a69b6fe776e6861","anchor_block":69923247},"proof":["0xb62562aa2cae2b8ad303f9b65ef98310cba6c4d9ac1f9bd51646827d60c33dd9","0x2da5914226173a353cd50b42c95cdb483f49203b9cabef4c3be99191cd20bef1","0x8868bf7ba9d1602e34c012ed5124e6c552f817050fe8fe9ea5de84b4b48181d3","0xb982a85963aa57e48a0f98387155335ad7265a7fda9fe28357d9dd82b444507a","0x802a8e8968203d831ad68b5c1bb42dc0b01b114cbfaddccdae840ff911909639","0x4faaf6d59b0514c262adccf832d60c8daf80bbaf3ee70abaef4acd8a6099234b","0x7c51420e072df52a0286875d48f08026f3bc3ddaef192e58d4c04c2cf92763a5","0x1351ddd498b5b0ed667cf6e91b4e7dd700f00a2fac04da424719e6a519fd75ec","0x2b4ab467dacd61d97bcf21e73d8029526528ce00c2661e73698a76f898eb3749","0x487c865fbcb0d7f9fb113dcde5173f80a22041121ceba11949b794c4c65d4e5e","0x40ebc91c42e796011975ed36119721b4aaeb6f47827a51bd9fceff174d2bfcfd","0x82afd42380b9419da914e81b1a060e5a4afd7a64384d71a3041d840a811f646f","0x5643b9288b814282552e201f88aaff802fe65d56312c6c392b831728b9fe829f","0x4ac91605f15503f7d7aa9a25d4e54c100a1a62c26e93a7ed87049569e871a9a4","0xa0b1f6bc1eecfaf70581673c1a7f638b96d1769a5c578c460337f7db0dbe963e","0x0c59b8770d2782eb535aefbb9b2f6810bab4757f51b37e00f5147713a1de9481","0x61ef83255d34604cb052882568ca1d1386ac3cfb8284509715bc1734cff77831","0x0c43c73b62a5d49ee1444b5dc4195fc5b16b141d3f4458e2e9fbd5fd6ecb367d"]}